Hospital de Sant Joan Despi Moises Broggi
- Address
- Calle Jacint Verdaguer 90, 08970 Sant Joan Despí, Spain
Hospital de Sant Joan Despi Moises Broggi - Otolaryngology & Vestibular Research
Hospital de Sant Joan Despi Moises Broggi is actively engaged in clinical research focusing on otological and vestibular disorders. The center participates in international multicenter trials evaluating innovative therapeutic approaches for inner ear pathologies, with particular emphasis on chronic vestibular conditions affecting balance and hearing.
- Menière's disease treatment optimization and novel drug formulations
- Vestibular symptom management including vertigo, tinnitus, and hearing loss
- Comparative effectiveness studies of extended-release versus conventional pharmaceutical formulations
The research team at Hospital de Sant Joan Despi Moises Broggi specializes in evaluating pharmacological interventions for Menière's disease, a debilitating inner ear disorder characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness. Their expertise includes conducting rigorous double-blind, parallel-group studies to assess both efficacy and safety of prolonged-release drug formulations, with focus on improving patient compliance and quality of life through once-daily dosing regimens that may offer therapeutic advantages over conventional treatment schedules.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital de Sant Joan Despi Moises Broggi
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Baricitinib Versus TNF Inhibitors for Venous Thromboembolism Risk in Rheumatoid Arthritis: Phase 3b/4 Active-Controlled Study | Eli Lilly & Co. | Phase III | Not Recruiting | Jul 2019 | Apr 2025 |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adalimumab | 1 | Unknown | 2019-07-25 | 2019-07-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.